维普中文期刊产品整合服务
29篇 您的检索式:作者名="EKMEKCIOGLU M"
    题名 作者 年代 出处 被引量
1A temporal subsampling approach for muhiview depth map compress/on显示文摘EKMEKCIOGLU E WORRALL S T KONDOZ A M 2009IEEE Transactions on Circuits and Systems for Video Technology2009,19,8:1
2The isoprostane 8 -epi -PGF2α,is accumulated in coronary arteries isolated fromp atients with coronary artery disease显示文摘Mehrabi M R Ekmekcioglu C Tatzber F 1999Cardiovascular Research1999,43,:1
3The menopause and bladder weight显示文摘Aygen EM Ekmekcioglu O Basbug M 1999Int Urogynecol J Pelvic Floor Dysfunct1999,10,3:1
4Effects of sildenafil citrate on ejaculation latency, detumescence time, and refractory period : placebo-controlled, double-blind, crossover laboratory setting study显示文摘Ekmekcioglu O Inci M Demirci D 2005Urology2005,65,2:1
5Inhibition of nuclear factor - kappa B and nitric oxide by curcumin induces G2/ M cell cycle arrest and apoptosis in human melanoma cells 显示文摘Zheng M Ekmekcioglu S Walch ET 2004Melanoma Res2004,14,3:1
6Effects of sildenafil citrate on ejaculation latency,detumescence time,and refractory period:placebo-controlled,double-blind,laboratory setting study显示文摘Ekmekcioglu O Inci M Demirci D 2005Urology2005,65,2:1
7A novel mechanism by which N-(4-hydroxyphenyl)retinamide inhibits breast cancer cell growth:the production of nitric oxide显示文摘Simeone A M Ekmekcioglu S Broemeling L D 2002Mol Cancer Ther2002,1,12:1
8Effects of silden- afil citrate on ej aeulation latency, detumescence time, and refractory period: placebo controlled, dlube-blindcrossover, la- boratory setting study显示文摘Ekmekcioglu O Inci M Demirci D 2005Urology2005,65,2:1
9Fuzzy failure modes and effects analysis by using fuzzy TOPSIS-based fuzzy AHP显示文摘KUTLU A C EKMEKCIOGLU M 2012Expert Systems with Applications2012,39,1:1
10Inducible nitric oxide synthase(inos) and nitrotyrosine(nt) in human netastatic melanoma tumors correlate with poor survival显示文摘Ekmekcioglu S Ellerhorst J Smid C M 2000Clin Cancer Res2000,6,:1
11Effects of sildenafil citrate on ejaculation latency, detumescence time, and refractory period: placebo-controlled, double-blind, crossover laboratory setting study显示文摘Ekmekcioglu O Inci M Demirci D 2005Urology2005,65,2:1
12Inhibition of nuclear factor-kappaB and nitric oxide by curcumin induces G2/ M cell cycle arrest and apoptosis in human melanoma cells 显示文摘Zheng M Ekmekcioglu S Walch ET 2004Melanoma Res2004,14,3:1
13Suppression of immune response to an adenovirus vector and enhancement of intratumoral transgene expression by low-dose etoposide显示文摘 FANG B EKMEKCIOGLU S 1985Gene Ther1985,5,:1
14Fuzzy failure modes and effects analysis by using fuzzy TOPSIS-based fuzzy AHP 显示文摘KUTLU A C EKMEKCIOGLU M 2012Expert Systems with Applications2012,39,1:1
15A novel mechanism by which N-(4-hydroxyphenyl) retinamide inhibits breast cancer cell growth:the production of nitric oxide显示文摘SIMEONE A M EKMEKCIOGLU S BROEMELING L D 2002Mol Cancer Ther2002,1,12:1
16The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24 显示文摘Caudell E G Mumm J B Poindexter N Ekmekcioglu S Mhashilkar A M Yang X H 2002J Imrnunol2002,168,:1
17A temporal subsampling approach for muhiview depth map compression 显示文摘EKMEKCIOGLU E WORRALL S T KONDOZ A M 2009IEEE Transactions on Circuits and Systems for Video Technology2009,19,8:1
18Down-regulated mela-noma differentiation associated gene (MDA-7) expression in human melanomas显示文摘EKMEKCIOGLU S ELLERHORST J MHASHILKAR A M 2001Cancer2001,94,1:1
19Effects of sildenafileitrate on ejaculation latency, detumescence time, an-drefractoryperiod:plaeebo-contmued, double-blind, crossover laboratory setting study显示文摘EKMEKCIOGLU O INEI M DEMIRCI D 2005Urology2005,65,2:1
20Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival显示文摘Ekmekcioglu S Ellerhorst J Smid C M 2000Clin Cancer Res2000,6,12:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费